Philip Morris
Placental Toxicology
Fields
- Author
- Janson, V.E.
- Sastry, Bvr
- Type
- PSCI, PUBLICATION SCIENTIFIC
- BIBL, BIBLIOGRAPHY
- Area
- CARCHMAN,RICHARD/OFFICE
- Litigation
- Iwoh/Produced
- Characteristic
- EXTR, EXTRA
- ILLE, ILLEGIBLE
- MARG, MARGINALIA
- MISS, MISSING PAGES
- ILLE, ILLEGIBLE
- Site
- R530
- Named Organization
- Natl Inst on Drug Abuse
- NIH, Natl Inst of Health
- Study Center for Anesthesia Toxicology
- Vanderbilt Univ Medical Center
- Ctr, Council for Tobacco Research
- Hhs, Dept of Health and Human Services
- NIH, Natl Inst of Health
- Author (Organization)
- Crc Press
- Vanderbilt Univ Medical Center
- Named Person
- L, T.M.
- Master ID
- 2063633034/3485
Related Documents:- 2063633034-3485 Book 6 Tabs 1 - 39
- 2063633036-3041 Environment and Cancer: Who Are Susceptible ?
- 2063633043-3050 Risk Factors for Primary Lung Cancer Among Non-Smoking Women in Taiwan
- 2063633052-3058 Air Pollution and Respiratory Health Among Children with Asthmatic or Cough Symptoms
- 2063633060-3067 Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
- 2063633069-3073 Genetic Testing for Cancer Risk
- 2063633075-3080 Oncogenic Transcription Factors in the Human Acute Leukemias
- 2063633082-3086 Nucleic Acid-Based Methods of the Detection of Cancer
- 2063633088-3093 Original Paper Vegetable and Fruit Intake and the Risk of Lung Cancer in Women in Ain Barcelona, Spain
- 2063633095-3098 P53 Mutations in Human Head and Neck Cancer Cell Lines
- 2063633100-3109 People, Places and Coronary Heart Disease Risk Factors: A Multilevel Analysis of the Scottish Heart Health Study Archive
- 2063633111-3116 Sex Differences in Up-Regulation of Nicotinic Acetylcholine Receptors in Rat Brain
- 2063633118-3125 Risk Factors and Sex Differential in Coronary Artery Disease
- 2063633127-3135 the Causes and Prevention of Cancer Gaining Perspective
- 2063633137-3141 Socioeconomic Status, Number of Siblings, and Respiratory Infections in Early Life As Determinants of Atopy in Children
- 2063633143-3153 Biomonitoring Exposure to Environmental Tobacco Smoke (Ets) : A Critical Reappraisal
- 2063633249-3258 A Case-Control Study of Cytochrome P450 1a1, Glutathione S-Transferase M1, Cigarette Smoking and Lung Cancer Susceptibility (Massachusetts, United States)
- 2063633260-3266 Is Meta-Analysis A Valid Approach to the Evaluation of Small Effects in Observational Studies?
- 2063633268-3277 Childhood Asthma in Four Regions in Scandinavia: Risk Factors and Avoidance Effects
- 2063633279-3291 Lung Cancer
- 2063633293-3303 National Incidence of Smoking and Misclassification Among the U.S. Married Female Population
- 2063633305-3311 Fatty Foods and the Risk of Lung Cancer: A Case-Control Study From Uruguay
- 2063633313-3351 Tobacco Smoking
- 2063633353-3362 Smoking and Lung Cancer: Risk As A Function of Cigarette Tar Content
- 2063633364-3372 Tar Content of Cigarettes in Relation to Lung Cancer
- 2063633374-3378 Comments on : Law, M.R. Et Al., (970000) << Environmental Tobacco Smoke Exposure and Ischaemic Heart Disease: An Evaluation of the Evidence. >> Bmj, 970000, 315(7114) :980
- 2063633379
- 2063633380-3381 Comments on the Paper: 'environmental Tobacco Smoke Exposure and Ischaemic Heart Disease: An Evaluation of the Evidence'
- 2063633382-3389 'secondhand Cigarette Smoke Affects Blood Platelets, in A Way Which Increases the Likelihood of A Thrombus.' (Page 10)
- 2063633390-3392 Stanton Glantz Claims
- 2063633393-3425 'environmental Tobacco Smoke Exposure and Ischaemic Heart Disease: An Evaluation of the Evidence'
- 2063633426-3433 Environmental Tobacco Smoke Exposure and Ischaemic Heart Disease: An Evaluation of the Evidence. The Accumulated Evidence on Lung Cancer and Environmental Tobacco Smoke
- 2063633472-3474 Placental Toxicology
- 2063633476-3484 Lung Carcinoma Trends by Histologic Type in Vaud and Neuchatel, Switzerland, 740000 - 790000
- Date Loaded
- 07 Jun 1999
Document Images
Nicodne-].'-N-oxide
H
$(-)-Nicotine
/ v
Nor-nicotine
Nicotine
glucuronide
N-Methylnicotine Cotinine
/-~ 3- Pyridyl--~,-methylamino)-
C.arbinolamine butyraldehyde
• ~,-(3-Pyridyl--z-me~hylamino)-
butyric acid
Nicodne
~ninium ion
-y-3-Pyridyl-
oxobutyric acid
Cotinine is also extensively metabolized, with only about 13 to 17% excreted unchanged
in ~he urine?~-~ Sever~[ rnet~bo[kes of cotinine have been reported, including trans-3"-
hydroxycotinineJ~" 5"-hydroxycodnine.~ cotinine N-oxide.~ and cotinine methonium ion~
(Figure 6). Little is known abou~ ~he quantitative importance or" these metabo[ites.
Hydroxycotinine appeoxs to be a major memboliteY"~s wkh urinary, concen~ons exceeding
codnine by ~wo- to ~hmefo[d. Codnine N-oxide {s R minor membo[{~e {n humans, accounting
Oxidative degra~don of the py~o[idinc dng fo~s "/-3-pyddy[ oxobu~dc acid
nicotine an~o[ codnine, which ~s ~nher converted ~mo 3-pyddyI acetic acid (F~gum 7).
compound h~ been [demificd qu~imdve[y in hum~ urine.~
Benowi[z and his co[labomzo~ have me~umd qumdtadve ~pec~ of n~codne metabolic
profiles in man. L'~na~" excretion profiles of nicotine and ci~ht of i~s metaboli[cs have b~en
dete~incd"~ (Figure 8). According to ~eir studies, t I) a high pc~enmgc (avenging 88%) of
a systemic dose of nicotine can be accounted for by me~ufing nicotine ~d i~ metaboIites:
~2) the pattern of metabolism is similar when nicotine is inhaled or abso~ed t~nsde~alIy:
t3) there is considerable intc~ndividual vadability in the pattern of metabolism, but the pattern
is consistent for an individuak and (4) within individuals, the ext~nt of conjugation of nicotine
~d cotinine is highly co.elated, but neither is co.elated wi~ the extent of conjugation of
Y= hyd~xycotinine. ~is suggests that similar enzymes ~ involved in the conjugation of
nicodne and codnine and that a different enzyme may ~ involved in the conjugation of

5-I
Cotinine-N-oxide N-Mcttaylcotinine
~ CH~
J CH~
O t Hydroxycotinine
Cotinine OH
Nnr-eotinine N-metlaylbutyramide
~ Cotit~e -t-3-Pyridyl-
glueutoa2de oxobutyri¢ acid
FIGI.~'RI~ 6. Metal0olic scheme foe, the conversion of cotinine, a major metabolite of nicotine,
into hydroxy¢otinin¢,
.V-me~.vleotinin,. ¢otinine N.oxide. nort:otinine, and -p.3-pyridyl oxobutyrie acid. Cotinine and
its glucuronide. 3-
hydroxyeotmine, its glueuronide, and ¢otinine N-oxide are d~teeted in the urine after sysmmi¢
administration of
nicotine."t
3"-hydroxycotinine. 3"-Hydroxycotinine. cotinine, and nicotine account for 47%, 30%, and
15%. respectively, of the dose of nicotine in urine as free alkaloids or glucuronides. The levels
of their glucuronides in urine are higher than those of their free bases. Cotinine N-oxide,
nicotine N-oxide, and nomicotine are only minor metabolites in human urine and account for
only 9% of the dose of nicotine. There are no studies to indicate whether this metabolic pattern
remains the same or is altered during pregnancy.
B. COTINI'NE PLASMA LEV'ELS: QUALITATIVE MARKER OF SMOKING
The elimination half-life of nicotine after nicodne administration in man to a steady state
is about 2 h?~.e'v This half-life of nicodne is useful in p~dieting its accumulation rate in the
body with repetitive doses as well as the time course of its decline after cessation of dosing.
.assuming a half-life of 2 h. one would predict nicotine to accumulate over 6 to 8 h (3 to 4 half-
lives) of regular smoking and to persist at significant nicotine levels for 6 to 8 h after cessation
of smoking. Peaks and troughs follow the use of each cigarette, but after smoking a number
of cigarettes trough levels rise and the influence of peak levels becomes less important.
However. a more reliable marker whose levels are maintained constant is necessary, to
determine moderate use of cigarettes or other forms of tobacco.
Cotinine levels are of special interest as qualitative markers and quantitative indicators of
nicotine intake. Cotinine is present in the blood of smokers in much higher concentrations than

and Placental Func'tmn
-~-3-Pyridyl-
o×obutyric acid
3-Pyridytacetic acid
FIGURE 7. Metabolic scheme t'or the conversion of .pj-pyridyl oxobutyric formed from nicotine and/or
codnin+
mto .~-p.vrid¥! ~c~ic a~id (3-PAA). 3-P.~A is quafi~a~i~eiy de~ccd in urine of exl:~rnen~.al
animals:'
nicotine. Cotinine blood levels average about .~0 to 300 ng/ml in cigarette smokers.6~-~s After
cessation of smoking, levels decline with a half-life averaging 18 to 20 h (range I I to 37 h).
However, because of its tong half-tile, there is much tess fluctuation in cotinine concentrations
than in nicotine concentrations throughout the day.
C. PLACENTAL TRANSI~R OF NICOTINE AND ITS M~TABOLITES
Three types of experimental approaches indicate that nicotine crosses the placenta: (l)
securing nicotine or cotinine in umbilical blood after a mother uses tobacco preparations. (2)
monitoring the effects of nicotine on the fetus, and (3) measuring placental transfer of nicotine
in isolated human placental cotyledon. Nicotine has been found in amniotic fluid and umbili-
cal cord blood of neonates after maternal tobacco use/~-es
Nicotine infusion in pregnant sheep increases uterine vascular resistance and reduces
uterine blood flow. These effects appear to be mediated by catecholamine release..°,~o Both
cigarette ~moking and nicotine gum chewing increaqe fetal heart rate during the qecond
mme~ter in humans, consistent with sympathetic activation.'= During the third trimester in
humans, cigarette smoking or nicotine gum chewing decreases fetal heart rate and reduces
fetal breathing movements, both of which may be signs of fetal hypoxia:~-7~ or nicotine- or
catecholamine-induced release or" opioid peptides (enkephalins) in fetal brain:=.vs
There are no detailed in ~.itro studies on the placental transfer of nicotine or its metabolites
in placental cotyledon. In a preliminary, study. Sastry et al.:~ reported the transport of nicotine

i
56
Nornico~Jne
Placental Toxicology
~ Nicotine
10 20 30
Percent of
Go tmlne N-oxlcle
Nicotine N-oxide
3-Hydroxycotinine (HC) glucuronide
' 3-HC
~Cotinine glucuronide
~
Cotinine
Nicotine glucuromde
40 50 60
Systemic Dose of Nicotine
in isolated perfused cotyledon of normal human term placent~ The perfusion technique is
classical and. has be~n validated by several investigators.~-~ The placental cotyledon was
perfused with aerated (21%. O:. 5% CO,.) IC,~bs-Ringer bicarbonate buffer (pH 7.4. 37"C~
containing 2% albumin on both the maternal (2,30 ml. 15 ml/min, 0.6 in Hg) and fetal (93 ml.
1.75 ml/min. 1.75 in Hg) sides in a closed recirculadng system. Nicotine (2 rag) was added
to the maternal perfusate, and perfusate samples (I ml) were collected from both sides at
regular intervals and analyzed for nicotine content by high performance liquid chromatogra-
phy (HPLC~.~° In about 40 rain. tS.6q~ of the nicotine added to the maternal perfusate was
transferred to the fetal pwrfusate, and the matwmal/fetal concentration redo reached 1,0: this
was maintained for the next 60 rain. These results show rapid placenta[ transfer of nicotine.
consistent with its high lipid solubility.
D. THE HUMAN PLACENTA ~ A METABOLIC ORGAN IN SMOKERS
The function of placenta as a metabolic organ is of interest in several aspects: (l) metabo-
lism of nicotine and other tobacco alkaloids and components of tobacco smoke into toxic
components like nitrosamines, (2) induction of placental enzymes, and (3) conversion of
polyaromatic hydrocarbons (PAHs) into mutagenic metaboLites.
Most of the enzymes for biowansformations present in the Liver are also present in the
placenta. Induction compounds affecting liver enzymes also affect the inducible placental
metabolic pathways.8t This subject has been discussed in detail in several reviews and
articles.~Z-~s
Glucuronidadon, sulfation, and glutathione conjugation as well as reactions dependent on
cytochrome P-t-50, epoxide hydrase, catechol-O-mcthyltransferase, and monoamine oxidase

NONSS'IOKING MOTIIER
villus
SMOKING MO'rlIER
Vaso~onszricdon of
Umbilical Vcsscls
Vasoconstricdo~ of
Umbilica] V©sscls

6O
Placental Tm-icolo~y
TABLE 3
Influence of Nicotine on the Uptake of c~.Aminoisobutyric
Acid ((~-A[B) by Human Placental Villi~
Treazment K~ Y,,.,
(n) (nmol/I) (nmoUmin/g)
Irreversible
component
Control 114) "~ "~-
..-) _ 0.7 69 _ 8
Nicotine (8) 0.79 - 0.42 .0 _ 9
Adapted from Bamwell and Sast~')
E~ch value is a mean * SE from the number (n) of placentas subjected to
Ireatment with nicotine, which lowered both the Michaelis-Memen constant
(K,J and maximum velo~i~ (V.m) for a-AIB 07
B. MATERNAL SMOKING AND DEPRESSION OF AMINO ACID UPTAKE
BY PLACENTA
The fetus is dependent on placental transfer of amino acids from maternal to fetal circu-
lation for its requirements of amino acids.In The placental transfer of amino acids is a two-
step process: (1) active uptake of amino acids by placental trophoblast cells from the mother's
blood, and (2) passive diffusion of amino acids from placental trophoblast ceils into umbilical
venous blood. The first step is critical, and its efficiency may be depressed under placental
hypoxic conditions induced by maternal smoking. Nicotine and several components of to-
bacco smoke (carbon monoxide, cyanides, and nitrites) reduce active uptake of amino acids
by isolated human placental villi,u~.~-~-') Exposure of human placental villi to nicotine
inhibits the upt~. e of ct-aminoisobutyric acid (ct-AIB). a nonmetabolizable amin6 acid. and
decreases both the maximum velocity (V,,~) and the Michaelis-Menten constant (K,,) for
uptake of ~-AIB'~9 (Table 3). The inhibition is neither competitive, noncompetitive, nor
uncompetitive, indicating the complex nature of the inhibition of placental AIB uptake by
nicodne (Figure 10). Part of the inhibition is not reversible by washing the placental tissue.
which may be of significance in chronic smoking (Table 3). Concentrations of several
essential amino acids (val. met. lieu. leu. tyr, pbe. his) and nonessential amino acids (asp. glu.
gly. ala. arg) in the placental villi of nonsmoking mothers a,re about 30 to 50% higher than
those of smokers.''--'~:~ Concentrations of thr and phe are about 14 to I5% higher in the
placental villi of nonsmokers than in those of smokers. Maternal smoking decreases the uptake
of amino acids by the placenta and the net transfer of amino acids from maternal to fetal blood.
Therefore. fetal undernutrition for amino acids may partially explain fetal intrauterine growth
retardation in tobacco smokers.
C. MATERNAL SMOKING AND THE REGULATORY MECHANISMS FOR
AMINO ACID UPTAKE BY PLACENTAL TROPHOBLAST CELLS
c~-AIB, a nonmetabolizable amino acid. has been used as a model amino acid to study the
mechanisms of amino acid uptake by placental tissue. Several regulatory mechanisms have
been proposed for the cellular uptake of amino acids in the placenta: (1) the gam,maglutamyi
cycle.~-'#.t~ (2) placental acetylcholine release and amino acid transport coupling.~'~-~v.~-'°.~-'o
(3) phospholipid N-methylation in the plasma membraneJ~ and (4) oxidative energy
sources. 12~1.129
1. The Gammaglutamyl Cycle
The gammaglutamyl (GG) cycle has been postulated by Meister and Anderson~-'~ as a
mechanism for amino acid transport. A hypothetical model links the GG cycle to amino acid

III i
Sraoking and Pht¢'ental Function
A
o' ¢o " ~o ao ' ~:o ~
Nicotine (raM)
61
B
~oo!
5oo
o 400
o
•
• 300
I00
0
-5
0 5 10 15 2o 25
1/Concentration (AIB)
FIGIJ'RI~ 10. Inhibition of the uptake of ct-aminoisobu .tyric acid (a-AIB) by the human placental
villus. Data ate
summarized from Barnwell end Sastry.I1' (..~) Concentration*response curve for the uptake of
a-aminoisobutyric acid
in the presence of nicotine. "i'he ordinate represent~ the percent of control UO ratio II:
inrracellular concenn'ation: O:
extracellular concenmation~ for the uptake of Ct-AIB (uptake when no drug is present). No nicotine
was present in the
baths during preincubation. Exposure time = 2 h. Points ate means _. SE from a minimum of t0 values.
The control
UO ratio was 6.8 = 0.J. IB) T.vpical double reciprocal plots for the uptake of ct-AIB in the
presence and absence of
nicotine. Concenmation is expressed as IJJnol/l. velocity as rate of uptake in IJ.mol/g/min. The
straight lines were
established with linear re~,ression analysis by the method of least squares. In neither case did
these lines cross on the
abscissa or the ordinate. In the presence of
~ min/I. Both K~ and V,~, decreased in the presence of nicotine. (Control: V,,~ = 12 x I0"~
tool/g/rain. I~ ,, 0.26 x
.10-~ tool/l: 5 rru~f, nicotine: V,,.u = 8.J, x 10-" mol/.g/min. K,, = 0.23 x 10-~ tool/l). Slopes
of V,~, and K,, for ct-AIB
uptake in the presence and absence of nicotine suggest that the inhibition cannot be classified as
simple competitive.
noncompetitive or uncomp~-.titiv¢. The results from one placenta ~re presented and -,re
representative ot" eight
placentas studied tsee Table
I transport systems, y-Glutamyl transpeptidase tGGTP) plays a key r~le in the GG
cycle. It is
bound in the outside bilayer of the plasma membrane. Glutathione
(glutamylcysteinylglycin~)
• is continuously secreted onto the cell surt'aee, where GGTP transfers a glutamyl,
group to an
i incoming molecule of an amino acid. The products, glutamyl-amino acid and
cysteinylglycine,
are reabsorbed into the ceil. Most amino acid molecules are absorbed by
independent transport
systems. The number of these carrier molecules may be inversely related to the
degree of

Pl¢~¢'ental Toxicology
:lh,+~,.,T'.i. ;i • .i' :~;tmm;.~glul;.Ull.+, I-imfinu acid. Durra,=, ~arva~on oI" lh¢ cells I~r
amino acids
with low I¢veN nf extr:lccllul~lr amin+, :u'ids ~. m,,r~ mm,p~+rt cagier mtflc~ulcs arc induc+d and
mco~oratcd into th¢ plasma membrane. Thu~. ~amm:~gluramyl-amino acids may s¢~'¢ as
tran~mcmhran¢ or environmental signals t~r ~he uprak¢ or" amino acids by cells.~ Cells can
use cbe GG cycle tbr efficient recov¢~ of cysmin¢. Human cmphoblas~ic microvilli contain
high levels o~ GG~)c Maternal smokin~ du~n8 pregnancy decreases the activi=y and
of GGTP in the micmvillous pl~ma mcmb~n¢~:"=~: ~T~bl¢ 4). ~is d¢cre~¢s the
and abso~fion o). ~amma~luramyl-amino acids, si~nallin~ the cell m induce ~h¢ ~ynchcsis of
more ~mino ~cid tran~po~ c~¢~ ~nd ~o ins~ them ~nto ~h~ plasm~ membrane. ~ere ~s an
increase in ~h¢ uptake of ~-AIB. m~inly duc =o an increase in V~. in washed placenral villi
from .chronic smokers (Table 4). ~e induction or" placent~[ ~-AIB tr~nspo~ ~hes durin~
m~¢emal ~mokin8 can be pa~i=lly explained by depression o[ ~e GG cycle. However, in ~be
pmsenc~ of tobacco smoke component, the inc~¢d ca~¢r sysmms do nm fully compensate
~or ~be dep~ssion of the GG cycle. ~e effects of mammal smoking on componcn~ o~ ~be GG
cycle ocher ~ GG~ ~¢ no~ known.
2. Placental Acetylcholine and Regulation of Amino Acid Transport
The chemical transmitter function of acetylcho[ine LA.Ch) in nervous tissue is well estab-
lished. Human placenta is not innervated. The evolutionary appearance of ACh preceded that
of the nervous system. The ACh system is fully developed in the placenta during maturation
and development of the placenta and the fetus:-~ It is synthesized in the syncytiou'ophoblast
and is released into both the maternal and fetal circulations of the placenta. There are several
studies which indicate a coupling link between ACh release and active uptake of amino acids
from maternal blood. Atropine causes a reduction in the uptake of cc-AIB by isolated placental
villous==~ or placental fragmentsJ~.~ Four different types of choline acetyltransferase (ChA)
inhibitors depress the uptake of a-AIB by placental villus,n:.=:~-~-~s There is a positive corre-
lation between the inhibition of ChA, ACh synthesis by ChA. and the depression of o~-AIB
uph~k¢. P-xr~acellular Ca** must be present for placental release of ACh. The uptake of ce-AIB
by the placental villus is depressed by 90% in Ca--free medium:-~ Inhibition of ChA
decreases the synthesis of ACh and i~ release as well as a-AIB uptake in placental villi or
Placentas from women with preeclampsia have higher levels of ACh than control placentas.
but the outpm of ACh from preeclamptic placentas is si~mificantly reduced,tz~-*'~ The trans-
port of a-AIB from the maternaJ side to the fetal side is reduced in preeclamptic peffused
placenta. :'== These observations suggest tha~ feral intrauterine growth rer.~rdation in
preeclamptic
women can be partially explained by reduced placental ACh release and reduced amino acid
transport.
Clinical observations give further evidence )'or a )'unctional link between ACh and ~lacentai
• ".r:.m<fer ,,f ::2:ino ;:cid.-. Hi.='h cunccnti'atioa.,, of nicotine ~gcrcase placental ACh
releaseY')
Maternal smoking depresses placental transfer of amino acids:~'~.0pioids decrease ACh
release from placenta and depress amino acid uptake.~'-)~:-~-~ Cocaine decreases placental
ACh release as well as amino acid uptake?~ Tobacco smoking and addiction to opioids or
cocaine cause intrauterine growth retardation. All these observations suggest a link between
ACh release and amino acid transport in placenta.
There are only preliminary reports on the effects of chronic maternal smoking on the
placental ACh system)~-' Maternal smoking decreases placental ChA activity (Table 4). This
decrease may be due to decreased synthesis of ChA protein or inhibition of ChA. an enzyme
containing -SH groups, by Cd, Ca, and Ni in tobacco smoke. Further investigations are
necessary to completely evaluate the relationships among the placental AC'h system, maternal
smoking, and placental amino acid transport.

Smukin:¢ and Pl~tcc, ntal t"um'ti,n
TABLE 4
.Maternal Smoking and Changes in the Regulator)
of Amino Acid Trunsport in Placenta"
?*lean ± .',;EM•
p value t'~)r
Par'amele~ Nunsmokers I.~i0 Smoker~ I,M..~
~1~ vs. ~,1.,
Plasma membrane. GGTP
V~ of GGTP ~nmollmg pro[c~min~ 47.39 ~ 7.~7 15.50 : 2.73
<0.o2
Pl~ memb~e. PMT
PMT I ~fmol/mg p~tcin/min) 23.17 ~ I.~ 13.~) ~ 1.99
<0.02
Micmviscosi~y ~cP~ ~8 ~ 14 513 ~ 26
<O.t)2
Placental ~A
~A ,nmol ~Ch h~nncdlm~ pn~c~n/m~n 3.2 •
~-AIB upz~ ~w~shed placental viilih
[~ mzio 9..SO ~ 0.4 15.30 = o.~
<0.05
K~ ~ff) 0.~ ~ 0.41 1.45 ~ 0.62
<0.05
V~, mmol/~min} 30.7 ~
~3
• Emzh ~'aiu¢ is t~r 6-9 nonsmok~t~ or 4-.5 smokers: smukcrs u,~d 20 =,g c~garcffes/day. All va|u~s
arc summarized
from Sasl~" and Horst.~.~° Horsl and Sa.slryY~ Sa.slr}..,~' and Jan,,am et al.'.~
GGTP. ~ammaglutarn.~ l ~ranspepfida.,~: PMT. phospholipid N-melhyllranslcr'a.s¢: ChA. choline
ac¢lyhran.~eras¢:
¢t-AIB. ¢z-aminoisobu~ync acid: I and E. in|ra- and ~xlrac~llular conccn~ratiuns of o¢-A[B:
K,,..Michacli.,,-Mcmen
conslan! for ~h¢ uptake of c[-AIB by placemal villi: V ..,,. maximum velocity for ~h¢ uptake of
~-A[B by isolated
placental vdli.
3. Phospholipid N-Methylation in Placental Plasma Membrane
and Amino Acid Transport
Enzymatic methylations, in the presence of 5-adenosy[-|.-methionine [SAM) as a methyl
donor, play a significant role in several cellular functions. During the past decade, three of
these SAM-mediated methylations .have received special attention:'z:a'=-'~-~ (I) stepwise con-
version of membrane phosphatidylethanolamine (PE) to phosphatidyl-N-methylethanolamine
~PME}. phosphatidyl-..VaV-dimethylethanolamine ~PMME~. and phosphatidylcholine (PC) by
t~o phospholipid .\'-methyltransferases ~PMT [ and [I) in ~eve.-'al tissues: 12~ formation of
protein carboxymethylesters (PCME) by protein carboxymethylase ~PCM) in several cell
systems: and ~3) methylation of endogenous fatty acids by fatty acid carboxymethylases
(FACM') in several tissues. These methylations in placental human trophoblast have been
reviewed by Bamwell and Sastry?::
Enzymatic phospholipid N-methylation is known to occur in placental tissues.
Further. it has been demonstrated that increasing the intracellular levels of 5-adenosyl-~-
homocysteine (SAH), an inhibitor of phospholipid N-methylation, inhibits the uptake of
c¢-AIB by the human placental villus.~= SAH is not a selective inhibitor of any specific
enzymatic methylation: it inhibits all SAM-mediated enzymatic methylations. A question
arises as to which one of the SAM-mediated enzymatic methylations plays a significant
in the uptake ofcc-AIB by the placental villus. Amino acid uptake systems occur in the plasma
m~mbrane. Barnwell and Sastry~-'v have analyzed the human placental villus for the above
three groups of enzymes involved in SAM-mediated methylations.~'-~ According to these
investigations, f I ) the relative distribution of PMT enzymes and amino acid carrier systems
~PCM and FACM) in the plasma membrane and placental villus homogenates and
depression of (z-AIB uptake by inhibition of PMT enzymes indicate that plasma membrane
phospholipid .V-methylation plays a more significant role than other types of methylations in
the uptake of amino acids by the human trophoblast.
tl

64
Placemal Toxicology
Increasing the intracellular level of SAH blocks both phospholipid N-methylation and
amino acid uptake by the placental villus under the same conditions. The blockade of amino
acid transport is not complete. When phospholipid :V-methylation is blocked more than 60%.
amino acid uptb, ke decreases by only about 40%. There might be a basal level of amino acid
uptake which is not regulated by phospholipid N-methylation. High SAH levels inhibit PCM
and FACM in addition to phospholipid N-methylation. The distribution of PMT L PMT II,
PCM, and FACM as well as the amino acid carrier systems (e.g.. GGTP) indicate that
phospholipid .V-methylation is possibly more intimately involved in the amino acid transport
across the plasma membrane of the trophoblast than the other two enzymatic methylations.
Phospholipid N-methyhransfemses contain active -SH ~roups. The cadmium ions in
tobacco smoke inhibit PMTs. The PMT I activity~'~.~" of placental plasma membranes
decreases in cigarette smokers~) (Table 4). However. it has yet to be evaluated whether the
decrease in PMT activity, is due to a decrease in the enzyme protein or the inhibition of the
enzyme by tobacco smoke components.
4. Oxidative Energy Sources and Placental Amino Acid Transport
Oxygen consumption by placental slices from smoking mothers decreased in proportion to
CoHb concentrations in maternal blood.~ The rate of oxygen consumption in placental slices
from nonsmoking mothers ( 1.9 p,l/mgjh) is about 30% higher than that in placental slices from
smoking mothers ( 1.3 gl/mg/h) at an 8% maternal CoHb concentration. These observations
indicate that the energy-dependent processes of placental cells may be depressed and that the
formation and concentrations of cellular ATP may be affected by hypoxia. All of the above
mechanisms for the regulation of amino acid transpor~ are ATP dependent. Three ATP
molecules are required for operation of the GG cycle and the uptake of one molecule of
garnrnaglutamyl-amino acid. Another ATP molecule is required to form one molecule of
acetyl.,coenzyrne, a substrat¢ for ChA to form one molecule of ACh. Still another ATP
molecule is required to form one molecule of SAM. Three molecules of SAM are required to
form one molecule of phosphatidylcholine by phospholipid methylation. Therefore. all pos-
tulated regulatory, mechanisms of amino acid u'ansport in the placenta may be indirectly
affected by maternal smoking. The effects of maternal smoking on placental ATP levels have
ye~ to be determined.
D. MATERNAL SMOKING AND TRANSFER OF AMINO ACIDS FROM
THE TROPHOBLAST TO THE UMBILICAL CIRCULATION
The placental trophoblasr cell membrane not only pumps amino acids into the cell but also
effects a net transfer across the cells into fetal interstitial fluid and thus into fetal
circulation.
Most essential amino acids are actively taken up by the placenta from the maternal circulation
and diffuse out into the fetal plasma. Both of these processes are influenced by maternal
smoking. The former is affected by placental hypoxia and the influence of components of
tobacco smoke on amino acid transpor~ systems and their regulation. The latter is influenced
by both hypoxia and release of biogenic amines (catecholamines and 5-hydroxytryptamine [~-
HT]) which cause constriction of.the umbilical vasculature.
The rate of oxygen consumption by placental slices from smoking mothers decreases in
proportion to CoHb levels in maternal blood,m Therefore, the energy-dependent processes of
placental cells may b~ depressed by hypoxia. These processes include actively transporting
amino acids, vitamins, and other substances. Smoking induces a certain amount of vascular
damage of placental vessels. Changes in umbilical arteries, villous arterioles, and villous
capillaries, have been observed in placentas from smoking mothers. These changes include a
broadening of the basement membrane, increased collagen content, decreased vascularization,
and pronounced intimal edema.*~:-m Depending on the degree of edema, the vascular diam-
eters will decrease and hinder blood flow in the umbilical arterial-venous system.
